Article
The EEG response to pyridoxine-IV neither identifies nor excludes pyridoxine-dependent epilepsy.
Epilepsia - 1 Dec 2010
Bok Levinus A, Maurits Natasha M, Willemsen Michèl A, Jakobs Cornelis, Teune Laura K, Poll-The Bwee Tien, de Coo Irenaeus F, Toet Mona C, Hagebeuk Eveline E, Brouwer Oebele F, van der Hoeven Johannes H, Sival Deborah A
Abstract excerpt
PURPOSE: Pyridoxine-dependent epilepsy (PDE) is characterized by therapy-resistant seizures (TRS) responding to intravenous (IV) pyridoxine. PDE can be identified by increased urinary alpha-aminoadipic semialdehyde (α-AASA) concentrations and mutations in the ALDH7A1 (antiquitin) gene. Prompt recognition of PDE is important for treatment and prognosis of seizures. We aimed to determine whether immediate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
